Kevin C. Tang, Chief Executive Officer, 10% Owner at Odonate Therapeutics, Inc. (ODT), bought 90,000 shares at $19.34 ($1.8M) on 2018-09-18, disclosed to the SEC on 2018-09-20.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.03 | 10,000 | $190K | 10.8% |
| 2 | $19.30 | 10,000 | $193K | 11.0% |
| 3 | $19.34 | 10,000 | $193K | 11.0% |
| 4 | $19.34 | 10,000 | $193K | 11.0% |
| 5 | $19.42 | 10,000 | $194K | 11.0% |
| 6 | $19.31 | 10,000 |
| $193K |
| 11.0% |
| 7 | $19.48 | 2,017 | $39K | 2.2% |
| 8 | $19.75 | 7,983 | $158K | 9.0% |
| 9 | $20.08 | 10,000 | $201K | 11.4% |
| 10 | $20.43 | 10,000 | $204K | 11.6% |
| Total | $19.55 avg | 90,000 | $1.8M | 100% |
| Filing → |
| ODT | BUY | 2020-12-23 | $8.4M | — | Filing → |
| LJPC | BUY | 2020-08-14 | $3.2M | — | Filing → |
| LJPC | BUY | 2020-02-03 | $1.7M | — | Filing → |